STAT: Early Price Setting, Other Market Access Planning is Key for Early-Stage Drug, Device Companies Back Bay in the News, Life Science MediaChristopher Leo, PhD October 29, 2019Drug Pricing, Market Access, Emerging BioPharma, Emerging Companies